16 research outputs found

    Exploring the Requirements for Technology Design to Support People with MCI or Early-Onset Dementia at Work

    Get PDF
    Work is an integral and meaningful part of many people’s lives. Research has shown that the consequences of mild cognitive impairment (MCI) and Early-Onset Dementia (EOD) before the age of sixty-five can profoundly affect a person’s vocational situation. Assistive technology plays an important role in supporting different abilities for people with MCI/EOD at communities and at home; however, there is little research to investigate the role of technology and address the technological requirements of people with MCI/EOD at work who are employed. This thesis proposes the cognitive task analysis - decision-centered design (CTA-DCD) model; a systematic human factors model to study people's tasks, activities, and requirements with the objective of developing a criteria for designing technology to support people with MCI/EOD at work. The CTA-DCD model was piloted with in-depth interviews with six people living with MCI/EOD and one caregiver. By characterizing the barriers or problems faced by people with MCI/EOD in the context of cognitive work, individual barriers of the participants in terms of macrocognitive activities and cognitive support requirements were characterized. The three design decisions that were derived for future technology design to support people with MCI/EOD at work were (1) having instruction options, (2) functions that support planning, and (3) display of important information and reminder prompts. The CTA-DCD model can be used systematically in different occupational contexts and domains in providing design decisions

    Separator fluid volume requirements in multi-infusion settings

    Get PDF
    INTRODUCTION. Intravenous (IV) therapy is a widely used method for the administration of medication in hospitals worldwide. ICU and surgical patients in particular often require multiple IV catheters due to incompatibility of certain drugs and the high complexity of medical therapy. This increases discomfort by painful invasive procedures, the risk of infections and costs of medication and disposable considerably. When different drugs are administered through the same lumen, it is common ICU practice to flush with a neutral fluid between the administration of two incompatible drugs in order to optimally use infusion lumens. An important constraint for delivering multiple incompatible drugs is the volume of separator fluid that is sufficient to safely separate them. OBJECTIVES. In this pilot study we investigated whether the choice of separator fluid, solvent, or administration rate affects the separator volume required in a typical ICU infusion setting. METHODS. A standard ICU IV line (2m, 2ml, 1mm internal diameter) was filled with methylene blue (40 mg/l) solution and flushed using an infusion pump with separator fluid. Independent variables were solvent for methylene blue (NaCl 0.9% vs. glucose 5%), separator fluid (NaCl 0.9% vs. glucose 5%), and administration rate (50, 100, or 200 ml/h). Samples were collected using a fraction collector until <2% of the original drug concentration remained and were analyzed using spectrophotometry. RESULTS. We did not find a significant effect of administration rate on separator fluid volume. However, NaCl/G5% (solvent/separator fluid) required significantly less separator fluid than NaCl/NaCl (3.6 ± 0.1 ml vs. 3.9 ± 0.1 ml, p <0.05). Also, G5%/G5% required significantly less separator fluid than NaCl/NaCl (3.6 ± 0.1 ml vs. 3.9 ± 0.1 ml, p <0.05). The significant decrease in required flushing volume might be due to differences in the viscosity of the solutions. However, mean differences were small and were most likely caused by human interactions with the fluid collection setup. The average required flushing volume is 3.7 ml. CONCLUSIONS. The choice of separator fluid, solvent or administration rate had no impact on the required flushing volume in the experiment. Future research should take IV line length, diameter, volume and also drug solution volumes into account in order to provide a full account of variables affecting the required separator fluid volume

    Treatment of Later Humoral Rejection with Anti-CD20 Monoclonal Antibody Rituximab: A Single Centre Experience

    Get PDF
    Humoral or vascular rejection is a B cell-mediated production of immunoglobulin (Ig) G antibody against a transplanted organ that results in immune complex deposition on the vascular endothelium, activation of the complement cascade, production of endothelial dysfunction and regional ischaemic injury

    Device for measuring bronchodilator delivery and response in resource-limited settings

    Get PDF
    corecore